Letters, Testimony & Comments

September 17, 2007
BIO's comments on the Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee (MedCAC)
September 14, 2007
BIO's comments to CMS regarding proposed changes
September 7, 2007
Comments on Notice Regarding the 340B Pricing Program; Children's Hospitals
August 27, 2007
Re: Docket No. 2006D-0347, Federal Register: July 26, 2007 (Volume 72, Pages 41081- 41083) Dear Sir/Madam, The following comments are provided by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology...
August 27, 2007
The Biotechnology Industry Organization (BIO) appreciates this opportunity tp provide the perspective of its members on the Bayh-Dole Act. BIO represents over 1,100 companies, universities, and research institutions using biotechnology to research...
August 17, 2007
BIO's comments on the CMS' Proposed Decision Memorandum.
August 16, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International Business's response to the U.S. Trade Representative's Federal Register notice of July 25, 2007, requesting...
July 30, 2007
Dear Senator: We are writing to convey our strong support for clean, renewable and domestic energy production. Accordingly, we urge you to support efforts in the Senate to approve energy tax legislation that will help promote the production and...
July 17, 2007
The Biotechnology Industry Organization (BIO) is pleased to submit these comments in response to the supplemental proposals for plant-incorporated protectants derived from plant viral coat protein genes (PVCP-PIPs) and for plant virus coat...
July 13, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments to the Department of Health and Human Services (HHS) on the HHS Public Health Emergency Medical Countermeasure Enterprise Implementation Plan for...
July 13, 2007
The Biotechnology Industry Organization (BIO) is pleased to submit these comments in response to the Advance Notice of Proposed Rulemaking (ANPRM) for Plant-Incorporated Protectants (PIPs); Potential Revisions to Current Production Regulation...